Author | dc.contributor.author | Carvajal Hafemann, Carlos | es_CL |
Author | dc.contributor.author | Iturra U., Sebastián | es_CL |
Author | dc.contributor.author | Justiniano Peralta, Juan | es_CL |
Author | dc.contributor.author | Bustamante Zamorano, Marco | es_CL |
Author | dc.contributor.author | Contreras P., Juan Eduardo | es_CL |
Author | dc.contributor.author | Lombardi Solari, Juan | es_CL |
Author | dc.contributor.author | Capetillo Fuentes, María | |
Admission date | dc.date.accessioned | 2008-11-27T16:37:45Z | |
Available date | dc.date.available | 2008-11-27T16:37:45Z | |
Publication date | dc.date.issued | 2006 | |
Cita de ítem | dc.identifier.citation | Rev Méd Chile 2006; 134: 481-484 | en |
Identifier | dc.identifier.uri | https://repositorio.uchile.cl/handle/2250/127569 | |
Abstract | dc.description.abstract | Gastrointestinal stromal tumors (GIST) are lesions whose diagnosis
and treatment have varied in the last decade. We report a 76 year-old male with a history of
eight episodes of upper gastrointestinal bleeding. A duodenography showed an elevated lesion in
the third portion of the duodenum with a central ulceration. It was initially managed with
tumorectomy and primary closure of the duodenum. The pathological study of the surgical
specimen revealed a low grade gastrointestinal stromal tumor. Three years later, the tumor
recurred and pancreatoduodenectomy was performed. Due to the high risk of malignant
potential, tumor size, number of mitoses and the presence of necrosis, imatinib mesylate was
started. The patient had a satisfactory evolution, without evidences of recurrence after 15
months of follow up. | en |
Lenguage | dc.language.iso | es | en |
Keywords | dc.subject | Duodenum | en |
Título | dc.title | Tumores estromales gastrointestinales duodenales | en |
Title in another language | dc.title.alternative | Duodenal gastrointestinal stromal tumors. Report of one case | en |
Document type | dc.type | Artículo de revista | |